본문 바로가기
KERD
논문KCI 등재

Induction Chemotherapy Plus Concurrent Chemoradiotherapy versus Concurrent Chemoradiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma in Children and Adolescents: A Matched Cohort Analysis

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류의학일반

초록

Purpose The purpose of this study was to evaluate the long-term clinical outcome and toxicity of induction chemotherapy (IC) followed by concomitant chemoradiotherapy (CCRT) compared with CCRT alone for the treatment of children and adolescent locoregionally advanced nasopharyngeal carcinoma (LACANPC). Materials and Methods A total of 194 locoregionally advanced nasopharyngeal carcinoma patients younger than 21 years who received CCRT with or without IC before were included in the study population. Overall survival (OS) rate, progression-free survival (PFS) rate, locoregional recurrence-free survival (LRFS) rate, and distant metastasis-free survival (DMFS) rate were assessed by the Kaplan-Meier method and a log-rank test. Treatment toxicities were clarified and compared between two groups. Results One hundred and thiry of 194 patients received IC+CCRT. Patients who were younger and with more advanced TNM stage were more likely to receive IC+CCRT and intensive modulated radiotherapy. The addition of IC before CCRT failed to improve survival significantly. The matched analysis identified 43 well-balanced patients in both two groups. With a median follow-up of 51.5 months, no differences were found between the IC+CCRT group and the CCRT group in 5-year OS (83.7% vs. 74.6%, p=0.153), PFS (79.2% vs. 73.4%, p=0.355), LRFS (97.7% vs. 88.2%, p=0.083), and DMFS (81.6% vs. 81.6%, p=0.860). N3 was an independent prognostic factor predicting poorer OS, PFS, and DMFS. The addition of IC was associated with increased rates of grade 3 to 4 neutropenia. Conclusion This study failed to demonstrate that adding IC before CCRT could provide a significant additional survival benefit for LACANPC patients. Further investigations are warranted.

Abstract

Purpose The purpose of this study was to evaluate the long-term clinical outcome and toxicity of induction chemotherapy (IC) followed by concomitant chemoradiotherapy (CCRT) compared with CCRT alone for the treatment of children and adolescent locoregionally advanced nasopharyngeal carcinoma (LACANPC). Materials and Methods A total of 194 locoregionally advanced nasopharyngeal carcinoma patients younger than 21 years who received CCRT with or without IC before were included in the study population. Overall survival (OS) rate, progression-free survival (PFS) rate, locoregional recurrence-free survival (LRFS) rate, and distant metastasis-free survival (DMFS) rate were assessed by the Kaplan-Meier method and a log-rank test. Treatment toxicities were clarified and compared between two groups. Results One hundred and thiry of 194 patients received IC+CCRT. Patients who were younger and with more advanced TNM stage were more likely to receive IC+CCRT and intensive modulated radiotherapy. The addition of IC before CCRT failed to improve survival significantly. The matched analysis identified 43 well-balanced patients in both two groups. With a median follow-up of 51.5 months, no differences were found between the IC+CCRT group and the CCRT group in 5-year OS (83.7% vs. 74.6%, p=0.153), PFS (79.2% vs. 73.4%, p=0.355), LRFS (97.7% vs. 88.2%, p=0.083), and DMFS (81.6% vs. 81.6%, p=0.860). N3 was an independent prognostic factor predicting poorer OS, PFS, and DMFS. The addition of IC was associated with increased rates of grade 3 to 4 neutropenia. Conclusion This study failed to demonstrate that adding IC before CCRT could provide a significant additional survival benefit for LACANPC patients. Further investigations are warranted.

참고문헌 (27)

  1. Wei WI, "Nasopharyngeal carcinoma", Lancet, 365, pp.2041~2054 (2005)
  2. Levine PH, "Demographic patterns for nasopharyngeal carcinoma in the United States", Int J Cancer, 26, pp.741~748 (1980)
  3. Ingersoll L, "Nasopharyngeal carcinoma in the young: a combined M.D. Anderson and Stanford experience", Int J Radiat Oncol Biol Phys, 19, pp.881~887 (1990)
  4. Downing NL, "Comparison of treatment results between adult and juvenile nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 75, pp.1064~1070 (2009)
  5. Yan Z, "Nasopharyngeal carcinoma in children and adolescents in an endemic area: a report of 185 cases", Int J Pediatr Otorhinolaryngol, 77, pp.1454~1460 (2013)
  6. Guo Q, "Locoregionally advanced nasopharyngeal carcinoma in childhood and adolescence: Analysis of 95 patients treated with combined chemotherapy and intensity-modulated radiotherapy", Head Neck, 38(Suppl 1), pp.E665~E672 (2016)
  7. Sun Y, "Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial", Lancet Oncol, 17, pp.1509~1520 (2016)
  8. Ribassin-Majed L, "What is the best treatment of locally advanced nasopharyngeal carcinoma? An individual patient data network meta-analysis", J Clin Oncol, 35, pp.498~505 (2017)
  9. Casanova M, "International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents", Cancer Chemother Pharmacol, 77, pp.289~298 (2016)
  10. Rodriguez-Galindo C, "Treatment of childhood nasopharyngeal carcinoma (cNPC) with neoadjuvant chemotherapy (NAC) and concomitant chemoradiotherapy (CCRT): results of the Children's Oncology Group ARAR0331 study", J Clin Oncol, 34(15 Suppl) (2016)
  11. Zaghloul MS, "Does primary tumor volume predict the outcome of pediatric nasopharyngeal carcinoma?: A prospective single-arm study using neoadjuvant chemotherapy and concomitant chemotherapy with intensity modulated radiotherapy", Asia Pac J Clin Oncol, 12, pp.143~150 (2016)
  12. Varan A, "Pediatric and young adult nasopharyngeal carcinoma patients treated with preradiation cisplatin and docetaxel chemotherapy", Int J Radiat Oncol Biol Phys, 73, pp.1116~1120 (2009)
  13. Xiao WW, "Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study", Cancer, 117, pp.1874~1883 (2011)
  14. Ma J, "Is the 1997 AJCC staging system for nasopharyngeal carcinoma prognostically useful for Chinese patient populations?", Int J Radiat Oncol Biol Phys, 50, pp.1181~1189 (2001)
  15. Zhao C, "Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma", Ai Zheng, 23(11 Suppl), pp.1532~1537 (2004)
  16. Ma J, "Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: prognostic value and staging categories", Clin Cancer Res, 13, pp.1445~1452 (2007)
  17. Ozyar E, "Treatment results of 165 pediatric patients with nonmetastatic nasopharyngeal carcinoma: a Rare Cancer Network study", Radiother Oncol, 81, pp.39~46 (2006)
  18. Bakkal BH, "The efficiency of different chemoradiotherapy regimens in patients with paediatric nasopharynx cancer: review of 46 cases", Int J Clin Pract, 61, pp.52~61 (2007)
  19. Lu S, "Long-term outcomes of nasopharyngeal carcinoma in 148 children and adolescents", Medicine (Baltimore), 95, pp.e3445~ (2016)
  20. Orbach D, "Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: Radiotherapy dose adaptation after chemotherapy response to minimize late effects", Pediatr Blood Cancer, 50, pp.849~853 (2008)
  21. Tao CJ, "Longterm outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma", Chin J Cancer, 32, pp.525~532 (2013)
  22. Zubizarreta PA, "Nasopharyngeal carcinoma in childhood and adolescence: a single-institution experience with combined therapy", Cancer, 89, pp.690~695 (2000)
  23. Cheuk DK, "Prognostic factors and long-term outcomes of childhood nasopharyngeal carcinoma", Cancer, 117, pp.197~206 (2011)
  24. Rodriguez-Galindo C, "Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma", Cancer, 103, pp.850~857 (2005)
  25. Cannon T, "Nasopharyngeal carcinoma in young patients: a systematic review of racial demographics", Laryngoscope, 116, pp.1021~1026 (2006)
  26. Casanova M, "A prospective protocol for nasopharyngeal carcinoma in children and adolescents: the Italian Rare Tumors in Pediatric Age (TREP) project", Cancer, 118, pp.2718~2725 (2012)
  27. fluorodeoxyglucose positron emission tomography, "computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging", J Clin Oncol, 31, pp.2861~2869 (2013)

관련 논문AI추천

The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis계철승, 금기창, 김범석, 김연실, 김원택, 김지윤, 노재명, 문성호, 박효정, 송진호, 안용찬, 오동률, 오영택, 우홍균, 이창걸, 정웅기, 조관호, 조문준, 차지혜, 하정훈대한암학회 · Cancer Research and Treatment2016 · 제48권 제3호Individualized Concurrent Chemotherapy for Patients with Stage III–IVa Nasopharyngeal Carcinoma Receiving Neoadjuvant Chemotherapy Combined with Definitive Intensity-Modulated RadiotherapyCheng Lin, Jingfeng Zong, Pengjie Ji, Qiongjiao Lu, Shaojun Lin, Xiane Peng, Xiaoqiang Chen, Yuebing Chen, Zhiwei Chen대한암학회 · Cancer Research and Treatment2023 · 제55권 제4호Radiation Therapy Combined with (or without) Cisplatin-based Chemotherapy for Patients with Nasopharyngeal Cancer: 15-years Experience of a Single Institution in Korea강진형, 김민식, 김범수, 김연실, 김훈교, 문성권, 선동일, 유은정, 윤세철, 이연수, 정소령, 정수미, 조승호대한암학회 · Cancer Research and Treatment2008 · 제40권 제4호Role of Chemotherapy in Stage II Nasopharyngeal Carcinoma Treated with Curative Radiotherapy강민규, 강진형, 금기창, 김성환, 김연실, 김준원, 김지윤, 김진희, 문성호, 박근칠, 박준수, 박효정, 안용찬, 오동렬, 오영택, 우홍균, 이창걸, 조관호, 차지혜, 허대석대한암학회 · Cancer Research and Treatment2015 · 제47권 제4호Reduction of Target Volume and the Corresponding Dose for the Tumor Regression Field after Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaDehuan Xie, Jiang Hu, Lei Wang, Ruifang Zeng, Rui Zhong, Shaomin Huang, Shu Zhou, Wanqin Cheng, Yong Su, Zheng Wu대한암학회 · Cancer Research and Treatment2019 · 제51권 제2호Neutropenia during the First Cycle of Induction Chemotherapy Is Prognostic for Poor Survival in Locoregionally Advanced Nasopharyngeal Carcinoma: A Real-World Study in an Endemic AreaAi-Hua Lin, Cheng Xu, Guan-Qun Zhou, Jun Ma, Lei Chen, Ling-Long Tang, Rui Guo, Shi-Ping Yang, Wen-Fei Li, Xu Liu, Yan-Ping Mao, Ying Sun, Yuan Zhang대한암학회 · Cancer Research and Treatment2018 · 제50권 제3호

이 간행물의 다른 논문 (39건)